| Cancers, Vol. 13, Pages 492: ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer | Cancers | 1 hour | save |  |  |  |  |
| Cancers, Vol. 13, Pages 491: Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours | Cancers | 2 hours | save | | | | |
| Cancers, Vol. 13, Pages 490: Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention | Cancers | 3 hours | save | | | | |
| Cancers, Vol. 13, Pages 489: Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells | Cancers | 4 hours | save | | | | |
| Cancers, Vol. 13, Pages 488: Effects of 1-Year Hospital Volume on Surgical Margin and Biochemical-Failure-Free Survival in Patients Undergoing Robotic Versus Nonrobotic Radical Prostatectomy: A Nationwide Cohort Study from the National Taiwan Cancer | Cancers | 5 hours | save | | | | |
| Cancers, Vol. 13, Pages 485: Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer | Cancers | 5 hours | save | | | | |
| Cancers, Vol. 13, Pages 484: Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing | Cancers | 5 hours | save | | | | |
| Cancers, Vol. 13, Pages 487: DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model | Cancers | 5 hours | save | | | | |
| Cancers, Vol. 13, Pages 486: Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center | Cancers | 6 hours | save | | | | |
| Cancers, Vol. 13, Pages 481: Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations | Cancers | 6 hours | save | | | | |
| Cancers, Vol. 13, Pages 483: TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase | Cancers | 6 hours | save | | | | |
| Cancers, Vol. 13, Pages 482: Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients | Cancers | 7 hours | save | | | | |
| Cancers, Vol. 13, Pages 480: Integrinα3β1 Promotes Invasive and Metastatic Properties of Breast Cancer Cells through Induction of the Brn-2 Transcription Factor | Cancers | 7 hours | save | | | | |
| Cancers, Vol. 13, Pages 479: The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction | Cancers | 8 hours | save | | | | |
| Cancers, Vol. 13, Pages 478: Correction: Ahn, J.W., et al. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas. Cancers 2020, 12, 2543 | Cancers | 12 hours | save | | | | |
| Cancers, Vol. 13, Pages 477: Therapeutic Strategies for Targeting IL-1 in Cancer | Cancers | 20 hours | save | | | | |
| Cancers, Vol. 13, Pages 476: RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 475: No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 474: Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 473: The Interplay of Exosomes and NK Cells in Cancer Biology | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 472: Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 471: Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 468: Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 470: Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses and Disease Course in Patients with Papillary Thyroid Carcinoma | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 465: Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 469: The CXCL12 Crossroads in Cancer Stem Cells and Their Niche | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 467: Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 466: Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 464: Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 463: Cutaneous Findings in Neurofibromatosis Type 1 | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 461: Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 462: The Relevance of the SH2 Domain for c-Src Functionality in Triple-Negative Breast Cancer Cells | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 459: Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 460: Experimental Models for Studying HPV-Positive and HPV-Negative Penile Cancer: New Tools for An Old Disease | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 458: Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 457: Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery? | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 456: CD137+ T-Cells: Protagonists of the Immunotherapy Revolution | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 455: NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 454: Single-Fraction Adjuvant Electronic Brachytherapy after Resection of Conjunctival Carcinoma | Cancers | 1 day | save | | | | |
| Cancers, Vol. 13, Pages 453: Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 452: Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 451: Cancer of Unknown Primary: Challenges and Progress in Clinical Management | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 450: Early and Late Postoperative Seizures in Meningioma Patients and Prediction by a Recent Scoring System | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 449: Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 444: A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 446: A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 448: Diagnosis and Treatment of Primary and Secondary Lung Cancers | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 445: Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 447: K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review | Cancers | 2 days | save | | | | |
| Cancers, Vol. 13, Pages 443: Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours | Cancers | 2 days | save | | | | |
| | 
report | next » |
| |
